To assess whether assignment of docetaxel dose based on the ERMBT will result in decreased variability in drug area under the curve when compared to dosing based on body surface area. 12 months [clinicaltrials_resource:e041a171a45baed96d9ee9603c49fabd]
You will then receive your first dose of docetaxel chemotherapy. It is put through your IV over 1-2 hours. you will receive docetaxel every 3 weeks in the Cancer Center Infusion area.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To assess whether assignment of docetaxel dose based on the ERMBT will result in decreased variability in drug area under the curve when compared to dosing based on body surface area. 12 months [clinicaltrials_resource:e041a171a45baed96d9ee9603c49fabd]
You will then receive your first dose of docetaxel chemotherapy. It is put through your IV over 1-2 hours. you will receive docetaxel every 3 weeks in the Cancer Center Infusion area.
Bio2RDF identifier
e041a171a45baed96d9ee9603c49fabd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e041a171a45baed96d9ee9603c49fabd
measure [clinicaltrials_vocabulary:measure]
To assess whether assignment o ...... ng based on body surface area.
time frame [clinicaltrials_vocabulary:time-frame]
description
You will then receive your fir ...... e Cancer Center Infusion area.
identifier
clinicaltrials_resource:e041a171a45baed96d9ee9603c49fabd
title
To assess whether assignment o ...... n body surface area. 12 months
@en
type
label
To assess whether assignment o ...... 1a171a45baed96d9ee9603c49fabd]
@en